Uniquely positioned to support you in gaining and sustaining market access.
IMS has established a strong platform of information, analytics, and consulting to support the demonstration of product value to healthcare authorities across the world.
Our assets include:
-
The largest number of health economics and outcomes research specialists in the market with extensive experience at the national and international levels in Europe, Asia, Australia and the US
-
Access to the widest source of information including anonymized claims-based patient level data in the US, electronic medical records based patient data in Europe as well as global sales and prescription information
-
Expertise in applying health economics and outcomes research methodologies to your increasingly challenging commercial environment.
The IMS Health Economics and Outcomes Research combination of assets delivers unmatched insights and recommendations to clients in areas such as cost-of-illness studies, budget impact assessments, disease management models and compliance and persistence analyses.
The IMS Health Economics and Outcomes Research Continuum
